Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 3 (2006), Issue 6 (June)

1. Tau aggregation and progressive neuronal degeneration in the absence of changes in spine density and morphology after targeted expression of Alzheimer's disease-relevant tau constructs in organotypic hippocampal slices.
   J Neurosci, 26(22): 6103-14. [Abstract] [Full-text]
2. The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.
   J Neurosci, 26(22): 6069-76. [Abstract] [Full-text]
3. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease.
   J Neurol Sci, 246(1): 79-83. [Abstract] [Full-text]
4. Influence of lysosomal acid lipase polymorphisms on chromosome 10 on the risk of Alzheimer's disease and cholesterol metabolism.
   Neurosci Lett, 402(3): 262-6. [Abstract] [Full-text]
5. Association study of the PIN1 gene with Alzheimer's disease.
   Neurosci Lett, 402(3): 259-61. [Abstract] [Full-text]
6. Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer's disease.
   J Neurosci, 26(24): 6533-42. [Abstract] [Full-text]
7. Neuritic deposits of amyloid-beta peptide in a subpopulation of central nervous system-derived neuronal cells.
   Mol Cell Biol, 26(13): 4982-97. [Abstract] [Full-text]
8. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo.
   FEBS Lett, 580(15): 3582-8. [Abstract] [Full-text]
9. Synthesis and efficacy of 1-[bis(4-fluorophenyl)-methyl]piperazine derivatives for acetylcholinesterase inhibition, as a stimulant of central cholinergic neurotransmission in Alzheimer's disease.
   Bioorg Med Chem Lett, 16(15): 3932-6. [Abstract] [Full-text]
10. Neural substrates of cognitive and behavioral deficits in atypical Alzheimer's disease.
    Brain Res Brain Res Rev, 51(2): 176-211. [Abstract] [Full-text]
11. Severe cerebral congophilic angiopathy coincident with increased brain aluminium in a resident of Camelford, Cornwall, UK.
    J Neurol Neurosurg Psychiatry, 77(7): 877-9. [Abstract] [Full-text]
12. High-frequency cranial electrostimulation (CES) in patients with probable Alzheimer's disease.
    Am J Phys Med Rehabil, 85(7): 614-8. [Abstract] [Full-text]
13. Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40.
    Hum Mutat, 27(7): 686-95. [Abstract] [Full-text]
14. Donepezil effects on sources of cortical rhythms in mild Alzheimer's disease: Responders vs. Non-Responders.
    Neuroimage, 31(4): 1650-65. [Abstract] [Full-text]
15. Neighbored phosphorylation sites as PHF-tau specific markers in Alzheimer's disease.
    Biochem Biophys Res Commun, 346(3): 819-28. [Abstract] [Full-text]
16. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.
    Neurology, 66(12): 1850-4. [Abstract] [Full-text]
17. Voxel-based detection of white matter abnormalities in mild Alzheimer disease.
    Neurology, 66(12): 1845-9. [Abstract] [Full-text]
18. Neuropathology of older persons without cognitive impairment from two community-based studies.
    Neurology, 66(12): 1837-44. [Abstract] [Full-text]
19. Differences between Alzheimer's disease and dementia with Lewy bodies: an fMRI study of task-related brain activity.
    Brain, 129: 1780-8. [Abstract] [Full-text]
20. Targeting the role of the endosome in the pathophysiology of Alzheimer's disease: a strategy for treatment.
    Sci Aging Knowledge Environ, 2006(10): re2. [Abstract] [Full-text]
21. Dementia with cerebrovascular disease.
    Sci Aging Knowledge Environ, 2006(10): dn1. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.